Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (81-90 of 1,192) with videos related to

Pageof 120
Sort By:
Cancer Research|April 1, 1972
Biology and karyology of murine leukemia L1210 xenografted to the hamsterD M Goldenberg
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1972
On the involvement of serotonin in the tachyphylactic response to atropine, in vitroM M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|September 17, 2010
Pharmaceutical approval updateMarvin M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|January 4, 2011
Pharmaceutical approval updateMarvin M Goldenberg
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2006
Adjuvant and combined radioimmunotherapy: problems and prospects on the road to MinervaDavid M Goldenberg
Seminars in Nuclear Medicine|October 1, 1989
Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapyD M Goldenberg
Clinical Therapeutics|October 6, 1999
Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritisM M Goldenberg
Clinical Therapeutics|June 11, 1999
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladderM M Goldenberg
Current Opinion in Oncology|July 1, 1993
New imaging techniques in gastrointestinal cancerD M Goldenberg
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1976
F-461, 3-diethylamino-2,2-dimethylpropyl 5-(p-nitrophenyl)-2-furoate hydrochloride, a new non-anticholinergic spasmolytic and gastric acid inhibitorM M Goldenberg
Pageof 120

Showing results (81-90 of 1,192) with videos related to

Sort By:
Pageof 120
Cancer Research|April 1, 1972
Biology and karyology of murine leukemia L1210 xenografted to the hamsterD M Goldenberg
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1972
On the involvement of serotonin in the tachyphylactic response to atropine, in vitroM M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|September 17, 2010
Pharmaceutical approval updateMarvin M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|January 4, 2011
Pharmaceutical approval updateMarvin M Goldenberg
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2006
Adjuvant and combined radioimmunotherapy: problems and prospects on the road to MinervaDavid M Goldenberg
Seminars in Nuclear Medicine|October 1, 1989
Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapyD M Goldenberg
Clinical Therapeutics|October 6, 1999
Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritisM M Goldenberg
Clinical Therapeutics|June 11, 1999
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladderM M Goldenberg
Current Opinion in Oncology|July 1, 1993
New imaging techniques in gastrointestinal cancerD M Goldenberg
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1976
F-461, 3-diethylamino-2,2-dimethylpropyl 5-(p-nitrophenyl)-2-furoate hydrochloride, a new non-anticholinergic spasmolytic and gastric acid inhibitorM M Goldenberg
Pageof 120